You've chosen Americas as your location.

To clear your location selection and return to IPS Global, click below.

Return to IPS Global

You've chosen Americas as your location.

Thank you for choosing a location. This will help us show you the information that matters the most to you.

Continue Change Selection

mRNA vaccines for COVID-19 have put mRNA technology in the spotlight for many companies wanting to rapidly develop vaccines for infectious diseases and non-viral gene and cell therapy applications. The manufacturing process must be safe, reliable, efficient, low-cost, and flexible to allow on-demand production that meet regulatory requirements. To achieve successful these goals, developers will need in the early stage of their project to design a scalable manufacturing process taking advantage of single single-use technology and automation.

A well-defined product profile will help them to understand the future manufacturing scale and the challenges associated with it. Learn how to be successful in your production with a session from Catherine Jomary, PhD. at the PDA Ireland ATMP Conference.

Choose Your Location

To customize your experience, select an IPS region or country to view specific information based on your location.

  • Americas
  • United States
  • Canada
  • Brazil
  • All Other Countries

You’ve chosen as your location.

Thank you for choosing a location. This will help us show the information that means to most to you. Continue to the homepage to view featured projects, and happenings specific to your location.